Blood levels of vascular endothelial growth factor, the main marker of angiogenesis activity, and coagulation hemostasis were studied in CDF1 mice with transplanted P-388 lymphocytic leukemia. Blood levels of vascular endothelial growth factor increased by 168% in mice with tumors. The animals developed the hypercoagulation syndrome manifesting in shorter activated partial thromboplastin time and prothrombin time and development of hyperfibrinogenemia.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s10517-015-2793-0 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!